Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2026 · 10-Q
Revenue$295.88M$295.88M−0.4% vs Q2 2025 Net Income$38.01M$38.01M+8.9% vs Q2 2025 EPS Diluted$0.24$0.24+9.1% vs Q2 2025 Gross Profit$191,277,000−1.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$82,411,000−2.3% Free Cash Flowderived$76,490,000−1.3% Margins · derivedGross margin64.6%−0.6 pt vs Q2 2025
Operating margin18.4%+2.4 pt vs Q2 2025
Net margin12.8%+1.1 pt vs Q2 2025
ended Dec 31, 2025 · filed Feb 4, 2026 · 35 d after period end